SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001144204-15-066434
Filing Date
2015-11-17
Accepted
2015-11-17 16:06:56
Documents
1
Period of Report
2015-09-30
Effectiveness Date
2015-11-17

Document Format Files

Seq Description Document Type Size
1 NT 10-Q v424998_nt10q.htm NT 10-Q 23391
  Complete submission text file 0001144204-15-066434.txt   24628
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: NT 10-Q | Act: 34 | File No.: 001-36288 | Film No.: 151238270
SIC: 2834 Pharmaceutical Preparations